Picture of Biofrontera AG logo

B8FK Biofrontera AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Biofrontera Prelim FY Total Revenue Down At EUR 28.8 Mln

April 4 (Reuters) - BIOFRONTERA AG  B8FGn.DE :
    * PRELIMINARY FY TOTAL REVENUE DECREASED 5% TO EUR 28.8
MILLION,
COMPARED TO EUR 30.3 MILLION IN 2020
    * PRELIM FY PRO-FORMA EBITDA AND EBIT FOR 2021 ADJUSTED FOR
ONE-TIME EFFECTS ARE BOTH WITHIN GUIDANCE OF EUR -11 TO -14
MILLION FOR EBITDA AND EUR -13 TO -16 MILLION FOR EBIT
    * HAD A CASH POSITION OF EUR 6.9 MILLION AS OF DECEMBER 31,
2021,
COMPARED TO EUR 16.5 MILLION AS OF DECEMBER 31, 2020
    * ANTICIPATES TO GENERATE SALES BETWEEN EUR 24 MILLION AND
EUR 27
MILLION FOR 2022 FISCAL YEAR
    * EXPECTS EBITDA TO BE CLOSE TO BREAK-EVEN IN 2022 AND A
NEGATIVE
EBIT IN LOW SINGLE-DIGIT MILLION RANGE
    * IF MARKETS CONTINUE TO RECOVER, COMPANY EXPECTS INCREASING
REVENUES AS WELL AS POSITIVE EBITDA AND EBIT FROM 2023 ONWARDS

Source text for Eikon:  ID:nPex7lvdsa 
Further company coverage:  B8FGn.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Biofrontera AG

See all news